Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)
Rani Therapeutics Holdings (RANI) posted quarterly Long-Term Debt Issuances of $14.9 million for Q4 2022, up 1.58% quarter-over-quarter from $14.7 million in Q3 2022.
Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends
Rani Therapeutics Holdings' Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $14.9 million for Q4 2022.
- In Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $14.9 million; the TTM figure through Dec 2023 stood at $29.6 million (changed 0.0% YoY), while the FY2022 annual figure was $29.6 million, up 1619.42% from the prior year.
- Long-Term Debt Issuances for Q4 2022 stood at $14.9 million, up from $14.7 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $14.9 million in Q4 2022, with the low at -$1.5 million in Q4 2020.
- The 3-year median for Long-Term Debt Issuances is $2.8 million (2020), against an average of $6.5 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 14.90 Mn |
| Dec 31, 2022 | 14.90 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Mar 31, 2021 | 1.72 Mn |
| Dec 31, 2020 | -1.53 Mn |
| Dec 31, 2020 | -1.53 Mn |
| Sep 30, 2020 | 2.78 Mn |
| Sep 30, 2020 | 2.78 Mn |